Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009
Fri, March 6, 2009
Thu, March 5, 2009
Wed, March 4, 2009
Tue, March 3, 2009
Mon, March 2, 2009
Sun, March 1, 2009
Sat, February 28, 2009
Fri, February 27, 2009
Thu, February 26, 2009

DSM N.V.: DSM successfully issues long-term EUR 500 mln bond

  Copy link into your clipboard //business-finance.news-articles.net/content/200 .. cessfully-issues-long-term-eur-500-mln-bond.html
  Print publication without navigation Published in Business and Finance on , Last Modified on 2009-03-10 11:27:17 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

HEERLEN, NETHERLANDS--(Marketwire - March 10, 2009) -


DSM successfully issues long-term EUR 500 mln bond

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in The Netherlands, has successfully issued a EUR 500 million 5.75% bond due 2014.

The high demand from investors exceeded the companies' optimistic expectation. The order book had an exceptional high quality and totaled over EUR 2.4 billion and was closed early.

The proceeds will be used to refinance loans maturing in 2009 as well as to convert a substantial part of DSM's short term funding position into a long-term position, as this fits within DSM's conservative financial policy. Furthermore, it provides the company with sufficient financial flexibility, which is important in the current financial climate. Until 2013, when a loan of USD 150 million matures, DSM has no long-term refinancing needs.

The terms are laid down in the EUR 2.5 billion Debt Issuance Program of Royal DSM N.V., the final terms and the supplements thereto, which are available on the Investor Relations website.

The issue price was 99.240%. Based on this price the yield is 5.930%. The bond is listed on Euronext Amsterdam as of today.

This release does not constitute an offer or an invitation to subscribe for or purchase any securities. The notes are being offered only by means of a prospectus.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: [ www.dsm.com ]

 For more information: DSM Corporate Communications DSM Investor Relations Herman Betten Hans Vossen tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864 fax +31 (0) 45 5740680 fax +31 (0) 45 5782595 e-mail [ media.relations@dsm.com ] e-mail [ investor.relations@dsm.com ]

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.


Copyright © Hugin AS 2009. All rights reserved.